SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-214706
Filing Date
2023-08-17
Accepted
2023-08-17 07:10:58
Documents
15
Period of Report
2023-08-17
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d541263d8k.htm   iXBRL 8-K 24669
2 EX-99.1 d541263dex991.htm EX-99.1 87923
6 GRAPHIC g541263g0817031419209.jpg GRAPHIC 3828
7 GRAPHIC g541263g0817041024606.jpg GRAPHIC 3572
  Complete submission text file 0001193125-23-214706.txt   252865

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA selb-20230817.xsd EX-101.SCH 2860
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE selb-20230817_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE selb-20230817_pre.xml EX-101.PRE 10819
9 EXTRACTED XBRL INSTANCE DOCUMENT d541263d8k_htm.xml XML 3266
Mailing Address 65 GROVE STREET WATERTOWN MA 02472
Business Address 65 GROVE STREET WATERTOWN MA 02472 617-923-1400
SELECTA BIOSCIENCES INC (Filer) CIK: 0001453687 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37798 | Film No.: 231179787
SIC: 2834 Pharmaceutical Preparations